$7.16
1.70%
Nasdaq, Nov 28, 10:00 pm CET
ISIN
US30052C1071
Symbol
EOLS

Evolus, Inc. Target price 2025 - Analyst rating & recommendation

Evolus, Inc. Classifications & Recommendation:

Buy
85%
Hold
15%

Evolus, Inc. Price Target

Target Price $20.40
Price $7.16
Potential
Number of Estimates 8
8 Analysts have issued a price target Evolus, Inc. 2026 . The average Evolus, Inc. target price is $20.40. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 13 analysts: 11 Analysts recommend Evolus, Inc. to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Evolus, Inc. stock has an average upside potential 2026 of . Most analysts recommend the Evolus, Inc. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2031

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 266.27 301.92
31.76% 13.39%
EBITDA Margin -8.69% -5.83%
45.21% 32.89%
Net Margin -18.94% -10.28%
37.97% 45.71%

9 Analysts have issued a sales forecast Evolus, Inc. 2025 . The average Evolus, Inc. sales estimate is

$302m
Unlock
. This is
5.63% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$313m 9.40%
Unlock
, the lowest is
$289m 1.01%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $266m 31.76%
2025
$302m 13.39%
Unlock
2026
$383m 26.85%
Unlock
2027
$503m 31.25%
Unlock
2028
$610m 21.42%
Unlock
2029
$706m 15.68%
Unlock
2030
$855m 21.06%
Unlock
2031
$1.1b 24.71%
Unlock

6 Analysts have issued an Evolus, Inc. EBITDA forecast 2025. The average Evolus, Inc. EBITDA estimate is

$-17.6m
Unlock
. This is
46.01% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-18.1m 44.43%
Unlock
, the lowest is
$-16.9m 48.13%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-23.1m 27.81%
2025
$-17.6m 23.86%
Unlock
2026
$33.1m 287.86%
Unlock
2027
$99.5m 200.79%
Unlock
2028
$170m 70.49%
Unlock

EBITDA Margin

2024 -8.69% 45.21%
2025
-5.83% 32.89%
Unlock
2026
8.64% 248.20%
Unlock
2027
19.79% 129.05%
Unlock
2028
27.80% 40.47%
Unlock

9 Evolus, Inc. Analysts have issued a net profit forecast 2025. The average Evolus, Inc. net profit estimate is

$-31.1m
Unlock
. This is
46.98% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-27.2m 53.55%
Unlock
, the lowest is
$-32.4m 44.72%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-50.4m 18.27%
2025
$-31.1m 38.42%
Unlock
2026
$21.3m 168.50%
Unlock
2027
$64.3m 202.30%
Unlock
2028
$125m 94.81%
Unlock
2029
$181m 44.16%
Unlock
2030
$232m 28.60%
Unlock
2031
$359m 54.77%
Unlock

Net Margin

2024 -18.94% 37.97%
2025
-10.28% 45.71%
Unlock
2026
5.55% 153.99%
Unlock
2027
12.79% 130.45%
Unlock
2028
20.52% 60.44%
Unlock
2029
25.58% 24.66%
Unlock
2030
27.17% 6.22%
Unlock
2031
33.71% 24.07%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2031

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.81 -0.48
25.00% 40.74%
P/E negative
EV/Sales 1.88

9 Analysts have issued a Evolus, Inc. forecast for earnings per share. The average Evolus, Inc. EPS is

$-0.48
Unlock
. This is
47.25% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.42 53.85%
Unlock
, the lowest is
$-0.50 45.05%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.81 25.00%
2025
$-0.48 40.74%
Unlock
2026
$0.33 168.75%
Unlock
2027
$0.99 200.00%
Unlock
2028
$1.93 94.95%
Unlock
2029
$2.79 44.56%
Unlock
2030
$3.59 28.67%
Unlock
2031
$5.55 54.60%
Unlock

P/E ratio

Current -7.87 45.67%
2025
-14.94 89.88%
Unlock
2026
21.80 245.92%
Unlock
2027
7.21 66.93%
Unlock
2028
3.70 48.68%
Unlock
2029
2.57 30.54%
Unlock
2030
2.00 22.18%
Unlock
2031
1.29 35.50%
Unlock

Based on analysts' sales estimates for 2025, the Evolus, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.98 41.07%
2025
1.88 5.26%
Unlock
2026
1.48 21.17%
Unlock
2027
1.13 23.81%
Unlock
2028
0.93 17.64%
Unlock
2029
0.80 13.55%
Unlock
2030
0.66 17.40%
Unlock
2031
0.53 19.82%
Unlock

P/S ratio

Current 1.62 49.46%
2025
1.54 5.33%
Unlock
2026
1.21 21.17%
Unlock
2027
0.92 23.81%
Unlock
2028
0.76 17.64%
Unlock
2029
0.66 13.56%
Unlock
2030
0.54 17.39%
Unlock
2031
0.44 19.82%
Unlock

Current Evolus, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BTIG
Locked
Locked
Locked Sep 08 2025
HC Wainwright & Co.
Locked
Locked
Locked Aug 06 2025
Needham
Locked
Locked
Locked Aug 06 2025
BTIG
Locked
Locked
Locked Aug 06 2025
Needham
Locked
Locked
Locked May 08 2025
BTIG
Locked
Locked
Locked Apr 17 2025
HC Wainwright & Co.
Locked
Locked
Locked Apr 10 2025
Analyst Rating Date
Locked
BTIG:
Locked
Locked
Sep 08 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Aug 06 2025
Locked
Needham:
Locked
Locked
Aug 06 2025
Locked
BTIG:
Locked
Locked
Aug 06 2025
Locked
Needham:
Locked
Locked
May 08 2025
Locked
BTIG:
Locked
Locked
Apr 17 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Apr 10 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today